Astrocytes-derived exosomes pre-treated by berberine inhibit neuroinflammation after stroke via miR-182-5p/Rac1 pathway
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110047 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Wangli Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Nanjing First Hospital, China Pharmaceutical University, Nanjing, China; Department of Pharmacy, Nanjing First Hospital, Nanj…. Hauptthemen laut MEDLINE: Berberine, Exosomes, Stroke, MicroRNAs. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Family Planning Commission of the People's Republic of China.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Our previous studies have shown that berberine can improve the nerve function deficits in ischemic stroke by inhibiting inflammation. The cellular communication between astrocytes and neurons via exosomes might affect neurological function after ischemic stroke, which plays a vital role in the therapy of ischemic stroke. OBJECTIVE: The present study focused on the effects of exosomes released from astrocytes induced by the glucose and oxygen deprivation model with berberine pretreatment (BBR-exos) treatment for ischemic stroke and its regulatory mechanism. METHODS: Oxygen-glucose-deprivation/Reoxygenation (OGD/R)-treated primary cells were used to mimic cerebral ischemia/reperfusion conditions in vitro. With the treatment of BBR-exos and exosomes released from primary astrocytes induced by the glucose and oxygen deprivation model (OGD/R-exos), the cell viability was detected. C57BL/6J mice were used to establish middle cerebral artery occlusion/reperfusion (MCAO/R) model. The anti-neuroinflammation effects of BBR-exos and OGD/R-exos were evaluated. Subsequently, the key miRNA in BBR-exos was identified by exosomal miRNA sequencing and cell validation. miR-182-5p mimic and inhibitors were provided to verify the effects in inflammation. Finally, the binding sites between miR-182-5p and Rac1 were predicted online and verified by using a dual-luciferase reporter assay. RESULTS: BBR-exos and OGD/R-exos both improved the decreased activity of OGD/R-induced neurons, and decreased the expression of IL-1β, IL-6 and TNF-α (all P < 0.05), which reduced neuronal injury and inhibited neuroinflammation in Vitro. And BBR-exos showed better effects (P < 0.05). The same effect has been verified in vivo experiments: BBR-exos and OGD/R-exos both reduced cerebral ischemic injury and inhibited neuroinflammation in MCAO/R mice (all P < 0.05). Likewise, BBR-exos showed better effects (P < 0.05). The exosomal miRNA sequencing results showed that miR-182-5p was highly expressed in BBR-exos and inhibited neuroinflammation by targeting Rac1 (P < 0.05). CONCLUSION: BBR-exos can carry miR-182-5p to injured neurons and inhibit the expression of Rac1, which could inhibit neuroinflammation and improved brain injury after ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Nanjing First Hospital, China Pharmaceutical University, Nanjing, China; Department of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
- Department of Pharmacy, Shanghai Children's Medical Center, Medical Department, Shanghai Jiao Tong University, Shanghai, China.
- Department of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
- Key Lab of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China. Electronic address: jgsun@cpu.edu.cn.
- Department of Pharmacy, Nanjing First Hospital, China Pharmaceutical University, Nanjing, China; Department of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: junrong_zh…
Förderung
- National Health and Family Planning Commission of the People's Republic of China
Zitieren
APA
Ding, W., Gu, Q., Liu, M., Zou, J., Sun, J., & Zhu, J. (2023). Astrocytes-derived exosomes pre-treated by berberine inhibit neuroinflammation after stroke via miR-182-5p/Rac1 pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110047
Vancouver
Ding W, Gu Q, Liu M, Zou J, Sun J, Zhu J. Astrocytes-derived exosomes pre-treated by berberine inhibit neuroinflammation after stroke via miR-182-5p/Rac1 pathway. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110047
BibTeX
@article{Ding2023,
author = {Ding, Wangli and Gu, Qiuchen and Liu, Manman and Zou, Junqing and Sun, Jianguo and Zhu, Junrong},
title = {Astrocytes-derived exosomes pre-treated by berberine inhibit neuroinflammation after stroke via miR-182-5p/Rac1 pathway},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110047}
}
EUVIMED